ABCD launches nationwide COVID-19 and diabetes audit
A COVID-19 and diabetes national audit has been launched in a bid to gain more understanding of how the virus has impacted people with either type 1 or type 2.
The Nationwide ABCD Audit has been launched to capture detailed real-world data on the clinical presentation, co-morbidities, therapies, and outcomes in those admitted to hospital with COVID-19 and diabetes.
Dr Bob Ryder, Clinical Lead, ABCD Nationwide Audits, said: “We may have passed the initial peak of COVID-19, but we are only starting to understand the impact of COVID-19 on people living with diabetes.
“Sadly, almost a third of those who died during the pandemic in the UK had diabetes. Data from NHS England identified that those with type 1 and type 2 diabetes had a 3.5- and 2- fold increased risk of excess death, respectively. Many unanswered questions remain.
“ABCD are keen to explore the relationship between COVID-19 and diabetes in more detail, through a national audit. By capturing detailed real-world data on the clinical presentation, co-morbidities, therapies, and outcomes in those admitted to hospital with COVID-19 and diabetes we hope to provide more thorough insights into the impact of COVID-19. Ultimately this audit will provide much needed data to help inform future policy and management.”
The audit is open to both ABCD members and non-members to join.
For more information or take part, click here.